SNX-5422

Esanex Has Successful Ph II Meeting with FDA Meeting for SNX-5422 Upcoming Trial in Neuroendocrine Tumors
CP Wire
Thu, 10/4/18 - 09:44 am
Esanex Inc
SNX-5422
neuroendocrine tumors
Esanex Has Successful Ph II Meeting with FDA Meeting for SNX-5422 Upcoming Trial in Neuroendocrine Tumors
Thu, 10/4/18 - 09:28 am
Esanex Inc
SNX-5422
neuroendocrine tumors